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Abstract
Aims: To evaluate the effects of pulmonary vein isolation (PVI) in terms of feasibility, safety 
and success rate on a midterm follow-up period in septuagenarians undergoing ablation with the 
Arctic  Front  Cryoballoon for  atrial  fibrillation  (AF).                                      
Methods and Results: We prospectively enrolled 21 patients aged 70 years or older (14 male; 
age 73 ± 2.5 years) elected to circumferential PVI with the 28mm cryoballoon for symptomatic 
drug resistant paroxysmal AF. A total number of 82 pulmonary veins (PV) were evidenced. 
Successful isolation could be obtained in all 82 (100%) PV ostia at the end of procedure. No 
major  complication  occurred during procedure.  At  a  mean follow-up of 11.5 ± 4.7 months 
following ablation,  62% of patients  did not  present  recurrence  of atrial  arrhythmias.        
Conclusion: Cryoballoon ablation may be feasible and safe in older patients. Moreover a large 
proportion of the latter did not present AF recurrence during follow-up.                            
Key  words: cryoballoon;  elderly;  atrial  fibrillation                                   
Introduction  
Transcatheter ablation has become a common and efficient technique in the treatment of drug 
resistant atrial fibrillation (AF). Since ectopic beats originating from the pulmonary veins (PV) 
have been shown to be the main trigger initiating AF [1,2], electrical isolation of these venous 
structures  has  certainly  become  the  most  widely  accepted  endpoint  when  performing  this 
procedure. Traditionally, PV isolation (PVI) is performed by creating radiofrequency (RF) 
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energy  lesions  with  of  a  focal  tip  catheter.  Since  AF  is  the  most  common  arrhythmia 
encountered in clinical practice and its incidence is known to augment with age, reaching more 
than 7% in septuagenarians [3,4], older patients might represent an interesting target group for 
PVI  procedures.  However,  as  patients  get  older,  fibrosis  and  fat  deposits  infiltrate  the 
myocardium leading  to  an  alteration  in  electroanatomical  atrial  substrate.  Conceptually  this 
might render older patients less responsive to AF ablation. Furthermore, elderly patients present 
more frequently co-morbidities such as hypertension or congestive heart failure. Also, an age of 
over 75 years is known to be an independent risk factor for embolic events. This might lead 
electrophysiologists to be more cautious when proceeding to ablations in the left atrium with a 
large  amount  of  lesions  in  these  individuals.  Fortunately,  recently  published data  seems to 
indicate that AF ablation using RF is safe and feasible in elderly patients [5,6]. Moreover, this 
procedure might also be very effective in this patient population reaching success rates of more 
than 80% at one year follow-up. Novel ablation catheters designed as balloons have proven very 
effective  in  achieving  PVI.  Specifically,  the  cryoballoon  (Arctic  Front,  Medtronic)  using 
cryothermic ablation energy has been reported to acutely achieve PVI in more than 90% of 
veins  [7,8].  In  the  present  study,  we  prospectively  evaluated  the  effects  of  PVI  using  the 
cryoballoon in terms of feasibility and safety in a series of elderly patients (aged ≥70 years old). 
To  our  knowledge,  this  is  the  first  study  conducted  on  such  an  old  poulation  undergoing 
cryoballoon  ablation.  In  fact,  all  previous  reports  available  in  the  literature  included  much 
younger  series  of  patients  [7-9].                                   
Methods  
Patient  characteristics                                           
In a larger series of consecutive patients undergoing PVI with the cryoballoon, all patients aged 
≥70 years old were prospectively enrolled in our study. A total of 21 patients (14 male; mean 
age  73±  2,5  years)  were  included  (see  Table  1 for  baseline  characteristics).  Four  patients 
underwent a previous RF PVI procedure using a point by point with electroanatomical mapping 
guidance in another center, with early AF recurrence following the ablation. Reports from the 
above mentioned 4 procedures indicate that PVI was successfully achieved in all veins by the 
use of a circular mapping catheter in the PV ostia during ablation All individuals signed an 
informed consent prior to procedure according to our institution's guidelines.  The study was 
approved  by  the  institutional  review  board.  Inclusion  criteria  were  based  on  the  frequent 
occurrence of recurrent episodes of AF, in spite of treatment with at least 2 antiarrhythmic drugs 
and patient age ≥70 years. To exclude the presence of thrombi in the left atrial appendage, all 
patients underwent 2D transesophageal echocardiography (TEE) the day before the procedure, 
along  with  a  transthoracic  echocardiography  (TTE)  enabling  assessment  of  left  atrial  (LA) 
dimensions, left ventricular and valvular function. Exclusion criteria were the presence of a LA 
thrombus, uncontrolled severe heart failure, or contraindications to general anesthesia. 
Ablation  procedure                                   
The  cryoballoon  ablation  procedure  was  carried  out  as  previously  described  in  detail  [7].  
Ablation  was  performed  under  general  anesthesia.  Briefly,  after  gaining  left  atrial  access, 
selective angiograms of the PVs were performed and baseline electrical  information using a 
circular mapping catheter (Lasso, Biosense Webster, Inc., Diamond Bar CA, USA) was aquired. 
Then a 28 mm double walled cryoballoon (Arctic Front, Medtronic, Minneapolis) was inflated 
in the LA and positioned sequentially in the PV ostium of each vein. Occlusion was considered 
to have been achieved when selective contrast injection showed total contrast retention with no 
backflow to the atrium (Figure 1). A minimum of 2 cryoenergy applications were performed 
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per vein. In order to avoid phrenic nerve palsy during cryoablation in the RSPV, a quadripolar 
catheter was placed in the superior vena cava and pacing was achieved by pacing the ipsilateral 
phrenic nerve and ensuring diaphragmatic contraction. During the whole procedure activated 
clotting time was maintained over 300 seconds by supplementing heparin infusion, as required. 
Table 1
Figure  1: Fluoroscopy  angiography  of  the  left  superior  pulmonary  vein  during  occlusion  with  the 
cryoballoon(arrow). Quadripolar catheter in the coronary sinus. PV:pulmonary vein; CS: coronary sinus.       
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Assessment  of  PV  isolation                                       
We recorded PV activity before and after ablation. Effective PV isolation was considered to have 
been obtained when all  PV potentials  were  abolished or  dissociated  from atrial  activity,  and 
bidirectional block was documented. Entry block was demonstrated by the absence of PV activity 
while pacing in the distal CS. Exit block was verified by pacing from each bipolar pair of the  
mapping catheter in the PV at 10 mA and 2 ms pulse width. Thirty minutes following electrical 
isolation, the circular mapping catheter was placed again sequentially in each PV ostium to verify 
persistence  of  the  result.                                       
Follow-up
All patients underwent physical examination and 24 hour Holter recordings at 1, 3, 6 days and a 5 
day  loop Holter  recording  12  months  after  the procedure.  Additional  Holter  monitoring  was 
performed if arrhythmic symptoms occurred. We considered a post-ablation blanking period of 2 
months.  Antiarrythmic  drugs  were  continued  during  the  blanking  period  and  then  stopped.
Statistical  analysis                                 
Continuous  variables  are  expressed  as  mean  ±  SD.  Categorical  variables  are  expressed  as 
percentages.
Results
Mean  total  procedure  time  was  129  ±  22  minutes  (from  skin  puncture  to  complete  sheath 
extraction from the groin). Mean total fluoroscopy time was 26 ± 6 min. Mean left atrial size was 
43 ± 3 mm. Mean duration of AF before procedure was 5.5 years. Structural heart disease was 
present in 5 patients (coronary artery disease=4; Valvular heart disease=1). Arterial hypertension 
under medical treatment was noted in 6 patients. Two patients presented with history of diabetes 
mellitus. Four patients exhibited a CHADS2 score of ≥2. During all procedures patients were in 
sinus rhythm and none developed atrial fibrillation at any stage. A total number of 82 PVs were 
targeted. Two discrete left sided common ostia were found. Thanks to the steerability of both the 
FlexCath (Cryocath, Montreal, Quebec, Canada) and the Lasso (Biosense Webster, Inc., Diamond 
Bar CA, USA), it was possible to map all PV ostia. Potentials were present in all PV ostia before 
ablation in patients that did not have a previous PVI. In the 4 patients that underwent a previous 
PVI procedure PV potentials were present in ≥3 veins (2 patients exhibited reconnection in 3 
veins and the other 2 in all 4 veins). All veins were targeted with the cryoballoon. Cryoballoon 
applications were also performed in the 2 veins exhibiting no baseline electrical activity because 
of  the  potential  beneficial  overlapping  effect  [9]  on  the  ipsilateral  interpulmonary  carina. 
Successful occlusion could be obtained in 76 (92.7%) PVs. In 12 PVs we performed more than 2 
CBA applications as optimal occlusion could not be reached with the first two. After a mean of 
2.3  (range  2-4)  cryoballoon  applications,  PV  isolation  with  bidirectional  block  could  be 
demonstrated in 78 (95%) of veins after cryoballoon applications  at first testing after ablation. 
Additional  lesions  with  a  cryothermal  focal  ablation  catheter  (Freezor  Max,  Medtronic, 
Minnesota, USA)  were needed to isolate the remaining 5% of veins (1 left superior PV (two 
applications on the LAA-LSPV ridge), 1 left inferior PV (single application in the posteroinferior 
region) and 2 right inferior PV (single application in the antero-inferior region; three applications 
in the inferior region)) in three different patients. After 30 minutes observational time, recovery 
occurred only in 2 (2.4%) right inferior PV. A single focal application in each vein led to their 
isolation.  At  the  end  of  the  procedure  all  82  (100  %)  veins  were  isolated.        
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Adverse  events                                           
Transient phrenic nerve palsy was observed in 3 patients when delivering energy in the RSPV 
(respectively after 156, 217 and 239 sec after starting the first cryoapplication). Diaphragmatic 
contraction completely recovered before the end of the procedure. Two patients experienced groin 
hematomas in the site of puncture. No patient experienced cerebrovascular injury, nor pericardial 
effusion causing acute hemodynamic impairement.                                          
Follow-up  
Clinical examination, baseline ECG and 24 hour ECG Holter registrations were performed at 1, 3 
and  6  months  after  the  procedure.  A 5  day  loop holter  was  systematically  performed  in  all  
patients at 12 months after ablation. At a mean follow-up of 11,5 ± 4,7 months, 8 patients (38%) 
experienced  arrhythmic symptoms.  During the first  two months,  2  patients  experienced  short 
episodes of sustained AF (documented on Holter monitoring). During the rest of the follow-up 
none of these patients  had AF recurrence.  Typical  right  atrial  flutter  was documented as  the 
clinical arrhythmia in one patient still experiencing symptoms. Following cavotricuspid isthmus 
ablation, the patient was free of arrythmias. Five patients experienced persistence of AF episodes 
during follow-up. Persistence of sinus rhythm could be achieved with single antiarrythmic drug 
(AAD) treatment in 4 patients. One patient was still symptomatic despite medical treatment with 
AADs. Due to failure of both drug therapy and ablation in this patient, a repeat procedure was 
proposed  but  was  refused.                                            
Discussion
AF  is  the  most  frequently  encountered  arrhythmia  in  occidental  society  reaching  epidemic 
proportions in the elderly population. It is in fact estimated that its incidence reaches more than 
7% in individuals between 70 and 80 years old [3,4]. Drug treatment of AF is known to be often 
ineffective in maintaining sinus rhythm. Consequently,  catheter  ablation is  increasingly being 
performed in electrophysiology laboratories around the world as it has proven an efficient tool to 
treat this arrhythmia [10]. As age related senescence is known to alter the pharmacokinetics of 
medical  treatment  making  the  metabolism  of  anti-arrhythmic  agents  less  predictable  (thus 
increasing the probability of side effects), [11,12] ablation might play a key role in preventing 
arrhythmic recurrence  also in  older  patients.  Furthermore,  as  the elderly  represent  the fastest 
growing segment of our population, studies focused on PVI in these patients have recently been 
reported in the literature. Corrado et al [5], described a surprisingly high rate of ablation success 
in a large cohort of patients over 70 years old following 2 ablation procedures. In fact 82% of 
patients were able to maintain sinus rhythm off AAD's with an additional 12% if medical therapy 
was  added.  Zado  et  al  [6]  report  similar  findings  in  their  single  center  observation.  A 
retrospective analysis of over 7 years concluded that it was possible to reach AF control in a high 
percentage of previously symptomatic despite drug treatment elderly patients (84% for patients 
aged between 65 and 74 years; 86% for patients over 75 years old). More importantly ablation in 
the  elderly  was  not  associated  to  increased  risk  of  complications  in  comparison  to  younger 
individuals. However, older patients were more likely to remain on anti-arrhythmic medication to 
achieve long-term control of the arrhythmia. The 2 abovementioned studies, however bare the 
obvious  limitation  of  both  being  retrospective  analyses.  A recent  prospective  observation  by 
Traub et al [13] reported a success rate of 60% at one year after one procedure in patients over 70 
years of age. Similarly to Zado et al the authors concluded that septuagenarians were more likely 
to continue anti-arrhythmic medication following ablation and that PVI was safe and feasible in 
this patient population. These studies were all conducted on patients undergoing PVI with RF 
energy. Novel ablation catheters designed as balloons have proven very effective in achieving 
PVI. Specifically, the cryoballoon (Arctic Front, Medtronic) using cryothermic ablation energy 
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has been reported to acutely achieve PVI in more than 90% of veins [7-9]. To our knowledge the 
present  study  is  the  first  prospective  observation  in  terms  of  safety,  feasibility  and  midterm 
outcome in a series of septuagenarians undergoing AF ablation with the cryoballoon. The study's 
main findings are that this technique might be safe and feasible in elderly patients achieving a 
high  rate  of  electrical  isolation  using  the  cryoballoon  approach.  In  terms  of  feasibility  we 
observed electrical isolation in all veins at the end of the procedure. In fact after a mean 2.3 
balloon applications per vein electrical isolation could be documented in 95% of venous ostia. 
Additional focal applications achieved electrical isolation in the remaining 5%. Also, cryoballoon 
PVI  might  be  safe  in  elderly  patients.  The  only  complication  that  required  additional 
hospitalization  days  was  a  right  sided  groin  hematoma  in  one  patient.  The  patient  was  not 
dismissed immediately for purely observational reasons. This adverse event might be considered 
more procedure than device related. As described in other studies, phrenic nerve palsy during 
cryoballoon is mostly reversible. In our series the large 28 mm balloon was used systematically. 
This probably resulted in more proximal lesions in the RSPV antrum with a lower possibility of 
phrenic nerve injury. Furthermore no CVA was observed. The cryothermal lesion itself might be 
part of the reason, as it is known to be less thrombogenic than RF [14]. However, this is a purely  
speculative statement and is strongly limited by the size of our population. Thus, larger trials 
evaluating CVA rate  following cryoballoon ablation in the elderly  are  warranted.  At  a  mean 
follow-up  of  11.5  months,  62%  of  patients  were  symptom  free  after  ablation  only.  This 
proportion is in the range of success of a single AF ablation procedure in younger patients [7,8]. 
This might indicate that even in the setting of a more remodelled atrial myocardium, triggers in 
the PVs might still be the main cause of paroxysmal AF in the elderly.  In our report 6 patients 
(29%) required further treatment following ablation. This finding is similar to the one reported by 
Zado et al stating that elderly patients are more liable to remain on antiarrythmic drugs to achieve 
AF control following RF ablation. However, conversely to younger patients in which AF freedom 
without drug therapy might be the primary clinical endpoint, in an elderly population affected by 
drug resistant AF, symptom relief following ablation might be considered a positive outcome 
even  if  drug  therapy  is  not  discontinued.                                              
Limitations  
Our study bares the limit of a single center study with a relatively small population. Furthermore, 
in our series the mean left trial diameter was roughly 43 mm and structural heart disease was 
present  in  only 5  patients  (24%) reflecting  a  relatively "healthy"  population despite  the  age. 
Larger atria and higher comorbidity might have led to a less favourable outcome. Moreover, no 
patient in our series exhibited abnormal anatomical features, such as extremely large common 
ostia or adjunctive veins with uncommon ostial position, which might have rendered PV isolation 
very  difficult  with  the  cryoballoon.                                           
Conclusion  
Cryoballoon ablation may be feasible and safe in older patients. Moreover a large proportion did 
not present AF recurrence during follow-up. Studies with larger number of elderly patients are 
warranted  in  order  to  confirm our  findings.                                              
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